Biotech firm leveraging AI to analyze protein interactions launches with $40M Series A funding

Gandeeva Therapeutics to use $40M from series A funding to develop their AI-enabled cryo-EM platform for end-to-end drug discovery, shaving down cost and time to produce drug candidates.